MIRO — Miromatrix Medical Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $92.95m
- $77.29m
- $0.95m
Annual income statement for Miromatrix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.25 | 0.047 | 0.033 | 0.953 |
| Cost of Revenue | ||||
| Gross Profit | 0 | -0.453 | -0.467 | 0.453 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 9.24 | 10.3 | 17 | 31.3 |
| Operating Profit | -8.99 | -10.3 | -17 | -30.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -8.5 | -10.1 | -17 | -30 |
| Net Income After Taxes | -8.5 | -10.1 | -17 | -30 |
| Equity in Affiliates | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -8.54 | -12.4 | -17.2 | -30 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -4.05 | -10.3 | -14.7 | -30 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.283 | -0.58 | -1.28 | -1.45 |
| Dividends per Share |